iNtRON Biotechnology Inc Cash Flow Reinvestment Rate
iNtRON Biotechnology Inc cash flow reinvestment rate. iNtRON Biotechnology Inc (048530) has a Cash Flow Reinvestment Rate of 0.88x as of March 2025, reinvesting ₩1.70 Billion (capex ₩321.62 Million plus investments ₩1.38 Billion) from operating cash flow of ₩1.94 Billion. Explore 048530 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of iNtRON Biotechnology Inc (2015–2023)
Cash flow reinvestment rate of iNtRON Biotechnology Inc from 2015 to 2023. Historical reinvestment intensity for iNtRON Biotechnology Inc across 6 annual periods. Explore iNtRON Biotechnology Inc (048530) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
iNtRON Biotechnology Inc Cash Flow Reinvestment Rate by Year (2015–2023)
iNtRON Biotechnology Inc cash flow reinvestment rate by year from 2015 to 2023. Year-by-year capital reinvestment analysis for iNtRON Biotechnology Inc. For the full cash flow conversion analysis, see how efficiently does iNtRON Biotechnology Inc generate cash.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 19.79x | ₩61.70 Billion | ₩3.12 Billion | ₩9.55 Billion | ▲ +157.7% |
| 2022 | 7.68x | ₩45.90 Billion | ₩5.98 Billion | ₩2.23 Billion | ▲ +207.6% |
| 2021 | 2.50x | ₩41.13 Billion | ₩16.47 Billion | ₩3.05 Billion | ▲ +38.5% |
| 2020 | 1.80x | ₩12.86 Billion | ₩7.13 Billion | ₩4.85 Billion | ▲ +634.2% |
| 2018 | 0.25x | ₩1.03 Billion | ₩4.20 Billion | ₩550.58 Million | ▼ -95.3% |
| 2015 | 5.19x | ₩8.83 Billion | ₩1.70 Billion | ₩6.30 Billion | — |